• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去氢木香内酯(DHC)可抑制雌激素缺乏引起的骨质疏松症。

Dehydrocostus lactone (DHC) suppresses estrogen deficiency-induced osteoporosis.

机构信息

Department of Orthopedics, Dongguan People's Hospital, Dongguan, Guangdong 523000, China.

Department of Orthopedics, The Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong 515041, China.

出版信息

Biochem Pharmacol. 2019 May;163:279-289. doi: 10.1016/j.bcp.2019.02.002. Epub 2019 Feb 2.

DOI:10.1016/j.bcp.2019.02.002
PMID:30721671
Abstract

Osteoporosis is a chronic bone lytic disease, because of inadequate bone ossification and/or excessive bone resorption. Even though drugs are currently available for the treatment of osteoporosis, there remains an unmet need for the development of more specific novel agents with less adverse effects. Dehydrocostus lactone (DHC), a natural sesquiterpene lactone, was previously found to affect the differentiation of inflammatory cells by inhibiting NF-κB pathways, and garnered much interest for its anti-cancer properties via SOCS-mediated cell cycle arrest and apoptosis. As NF-κB pathway plays an essential role in osteoclast differentiation, we sought to discover the biological effects of DHC on osteoclast differentiation and resorptive activity, as well as the underlying mechanisms on these effects. Our research found that DHC inhibited RANKL-induced osteoclast differentiation, bone resorption and osteoclast specific genes expression via suppression of NF-κB and NFAT signaling pathways in vitro. We further demonstrated that DHC protected against ovariectomy (OVX)-induced bone loss in mice and the protective effect was mediated at least in part through the attenuation of NF-κB signaling pathway. Thus, this study provides insight that DHC might be used as a potential pharmacological treatment for osteoporosis.

摘要

骨质疏松症是一种慢性溶骨性骨病,由于骨形成不足和/或骨吸收过度。尽管目前有药物可用于治疗骨质疏松症,但仍需要开发更具特异性、不良反应更少的新型药物。去氢木香内酯(DHC)是一种天然倍半萜内酯,先前的研究发现它通过抑制 NF-κB 通路影响炎症细胞的分化,因其通过 SOCS 介导的细胞周期阻滞和凋亡发挥抗癌特性而备受关注。由于 NF-κB 通路在破骨细胞分化中起着至关重要的作用,我们试图发现 DHC 对破骨细胞分化和吸收活性的生物学效应,以及这些效应的潜在机制。我们的研究发现,DHC 通过抑制 NF-κB 和 NFAT 信号通路,在体外抑制 RANKL 诱导的破骨细胞分化、骨吸收和破骨细胞特异性基因表达。我们进一步证明,DHC 可预防去卵巢(OVX)诱导的小鼠骨丢失,其保护作用至少部分是通过减轻 NF-κB 信号通路介导的。因此,这项研究提供了一些见解,即 DHC 可能被用作治疗骨质疏松症的潜在药理学治疗方法。

相似文献

1
Dehydrocostus lactone (DHC) suppresses estrogen deficiency-induced osteoporosis.去氢木香内酯(DHC)可抑制雌激素缺乏引起的骨质疏松症。
Biochem Pharmacol. 2019 May;163:279-289. doi: 10.1016/j.bcp.2019.02.002. Epub 2019 Feb 2.
2
Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.倍半萜内酯小白菊内酯通过抑制核因子κB活性来阻断脂多糖诱导的骨溶解。
J Bone Miner Res. 2004 Nov;19(11):1905-16. doi: 10.1359/JBMR.040919. Epub 2004 Sep 27.
3
Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.佛手柑内酯通过抑制 NF-κB 和 JNK 信号通路抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨质疏松症。
Biochem Biophys Res Commun. 2019 Feb 5;509(2):329-334. doi: 10.1016/j.bbrc.2018.12.112. Epub 2018 Dec 20.
4
Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.新橙皮苷抑制小鼠破骨细胞分化、骨吸收及去卵巢诱导的骨质疏松。
Mol Cell Endocrinol. 2017 Jan 5;439:369-378. doi: 10.1016/j.mce.2016.09.026. Epub 2016 Sep 21.
5
Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome function.去氢木香内酯通过调节 NFATc1 抑制破骨细胞分化,并通过调节迁移和溶酶体功能抑制破骨细胞活化。
FASEB J. 2019 Aug;33(8):9685-9694. doi: 10.1096/fj.201900862R. Epub 2019 May 30.
6
Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCγ1-Ca-NFATc1 signaling pathway and prevents ovariectomy-induced bone loss.青蒿琥酯通过抑制 PLCγ1-Ca-NFATc1 信号通路抑制 RANKL 诱导的破骨细胞生成,预防去卵巢诱导的骨丢失。
Biochem Pharmacol. 2017 Jan 15;124:57-68. doi: 10.1016/j.bcp.2016.10.007. Epub 2016 Oct 24.
7
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.马粟酸通过调节 RANKL 介导的 NF-κB 和 MAPK 信号通路抑制破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2011 Mar;26(3):644-56. doi: 10.1002/jbmr.242.
8
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
9
(-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.(-)-表儿茶素3-O-β-D-阿洛吡喃糖苷通过抑制核因子κB受体活化因子配体(RANKL)诱导的核因子κB(NF-κB)和活化T细胞核因子c1(NFATc-1)信号通路,预防去卵巢诱导的小鼠骨质流失。
BMC Complement Altern Med. 2017 May 3;17(1):245. doi: 10.1186/s12906-017-1737-9.
10
Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway.塞皮诺酸通过抑制非经典 NF-κB 通路抑制破骨细胞分化,延缓衰老性骨质疏松症小鼠模型的骨丢失。
Sci Rep. 2018 Apr 4;8(1):5625. doi: 10.1038/s41598-018-23912-3.

引用本文的文献

1
Biological and Medicinal Properties of Makino and Its Bioactive Products.牧野及其生物活性产物的生物学和药用特性。
Int J Mol Sci. 2025 Jun 20;26(13):5956. doi: 10.3390/ijms26135956.
2
Dehydrocostus Lactone Inhibits Microglia-Mediated Neuroinflammation by Targeting CYP2A6 to Improve Ischemic Brain Injury.去氢木香内酯通过靶向CYP2A6抑制小胶质细胞介导的神经炎症以改善缺血性脑损伤。
CNS Neurosci Ther. 2025 Jul;31(7):e70502. doi: 10.1111/cns.70502.
3
Trifolirhizin protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption.
三叶豆紫檀苷通过抑制破骨细胞分化和骨吸收来保护去卵巢诱导的小鼠骨质流失。
Heliyon. 2024 Jul 6;10(14):e34250. doi: 10.1016/j.heliyon.2024.e34250. eCollection 2024 Jul 30.
4
Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis.中药天然萜类化合物在骨质疏松症治疗中的角色演变
Front Endocrinol (Lausanne). 2022 May 16;13:901545. doi: 10.3389/fendo.2022.901545. eCollection 2022.
5
The Effects of Sesquiterpene Lactones on the Differentiation of Human or Animal Cells Cultured : A Critical Systematic Review.倍半萜内酯对培养的人或动物细胞分化的影响:一项批判性系统评价
Front Pharmacol. 2022 Apr 4;13:862446. doi: 10.3389/fphar.2022.862446. eCollection 2022.
6
Epimedium for Osteoporosis Based on Western and Eastern Medicine: An Updated Systematic Review and Meta-Analysis.基于中西医结合的淫羊藿治疗骨质疏松症:最新系统评价与Meta分析
Front Pharmacol. 2022 Mar 31;13:782096. doi: 10.3389/fphar.2022.782096. eCollection 2022.
7
Dehydrocostus Lactone Attenuates Methicillin-Resistant -Induced Inflammation and Acute Lung Injury via Modulating Macrophage Polarization.去氢木香内酯通过调控巨噬细胞极化减轻耐甲氧西林金黄色葡萄球菌诱导的炎症和急性肺损伤。
Int J Mol Sci. 2021 Sep 9;22(18):9754. doi: 10.3390/ijms22189754.
8
The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets.NLRP3 炎性小体在脑血管疾病发病机制中的作用及可能的治疗靶点。
ASN Neuro. 2021 Jan-Dec;13:17590914211018100. doi: 10.1177/17590914211018100.
9
Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation the NF-κB and MAPK Pathways.石榴皮素通过抑制破骨细胞生成以及炎症反应的NF-κB和MAPK信号通路对骨质疏松症的保护作用
Front Pharmacol. 2020 May 15;11:696. doi: 10.3389/fphar.2020.00696. eCollection 2020.
10
Modulation of bone turnover aberration: A target for management of primary osteoporosis in experimental rat model.骨转换异常的调节:实验性大鼠模型中原发性骨质疏松症治疗的一个靶点。
Heliyon. 2020 Feb 6;6(2):e03341. doi: 10.1016/j.heliyon.2020.e03341. eCollection 2020 Feb.